BIOMAT Database Logo BIOMAT Database Logo

A preliminary study of the effects of intravenous m-chlorophenylpiperazine, a serotonin agonist, in elderly subjects. 1989

B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and P A Newhouse, and D L Murphy
Unit on Geriatric Psychopharmacology, National Institute on Mental Health, Bethesda, MD 20892.

m-Chlorophenylpiperazine (m-CPP), a serotonin receptor agonist, is currently being investigated as a probe of serotonergic responsivity in various neuropsychiatric disorders. The safety of m-CPP in elderly populations and its potential usefulness in exploring possible serotonergic dysfunction in Alzheimer's disease and normal aging were assessed by examining the behavioral, neuroendocrine, and physiological effects of this agent in 15 elderly subjects (mean age 69 +/- 2 years): 9 Alzheimer patients and 6 healthy normal volunteers. Intravenous m-CPP (0.08 mg/kg) was well tolerated in all subjects and produced no serious adverse effects. The behavioral effects were modest; in particular, minimal anxiety was observed, a finding that contrasted to results from an earlier study reporting that intravenous m-CPP at a slightly higher dose induced marked anxiety and panic attacks in younger subjects. m-CPP produced significant increases in plasma cortisol and prolactin, and significant changes in blood pressure and temperature in these elderly subjects. The results of this preliminary study suggest that intravenous m-CPP is safe and well-tolerated in elderly subjects. Future studies at higher doses can now proceed to study more definitively the question of possible age- and disorder-related reductions in central nervous system (CNS) serotonergic responsivity.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011939 Mental Recall The process whereby a representation of past experience is elicited. Recall, Mental
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and P A Newhouse, and D L Murphy
Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans.
December 1985, The Journal of clinical endocrinology and metabolism,
B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and P A Newhouse, and D L Murphy
A dose-response study of intravenous m-chlorophenylpiperazine in normal subjects.
January 1992, Psychopharmacology,
B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and P A Newhouse, and D L Murphy
Intravenous administration of the serotonin agonist m-chlorophenylpiperazine (mCPP) increases extracellular serotonin in the diencephalon of awake rats.
December 1993, Neuropharmacology,
B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and P A Newhouse, and D L Murphy
Induction of migrainelike headaches by the serotonin agonist m-chlorophenylpiperazine.
June 1988, Clinical pharmacology and therapeutics,
B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and P A Newhouse, and D L Murphy
Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects.
August 1990, Psychiatry research,
B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and P A Newhouse, and D L Murphy
Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study.
January 1990, Psychopharmacology,
B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and P A Newhouse, and D L Murphy
The serotonin agonist m-chlorophenylpiperazine (mCPP) binds to serotonin transporter sites in human brain.
November 1995, Neuroreport,
B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and P A Newhouse, and D L Murphy
Neuroendocrine response to the serotonin agonist M-chlorophenylpiperazine in women with menstrual status migrainosus.
July 2003, Neuroendocrinology,
B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and P A Newhouse, and D L Murphy
The serotonin agonist, M-chlorophenylpiperazine, markedly increases levels of plasma catecholamines in the conscious rat.
October 1988, Neuropharmacology,
B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and P A Newhouse, and D L Murphy
m-Chlorophenylpiperazine as a probe of serotonin function.
December 1991, Biological psychiatry,
Copied contents to your clipboard!